Cutaneous extranasal NK/T-cell lymphoma.
Malignant neoplasm from natural killer (NK) cells are characterized by their positivity for CD56 and absence of monoclonal TCR gene rearrangement. We present the case of a 54-year-old man with a fungous mass in his left flank whose histological examination was consistent with cutaneous extranasal T/NK cell lymphoma. We review the literature and also discuss the prognosis and treatment of this variety of lymphoma.
Ruiz Villaverde
R
R
Department of Dermatology, Hospital Clínico Universitario San Cecilio, Granada, Spain. ismenios@hotmail.com
Blasco Melguizo
J
J
Juez Martel
I
I
Linares Solano
J
J
Naranjo Sintes
R
R
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001707:Biopsy, Needle; D019002:CD56 Antigen / Q000276:immunology; D003131:Combined Modality Therapy; D018450:Disease Progression; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D007694:Killer Cells, Natural / Q000473:pathology*; D016410:Lymphoma, T-Cell, Cutaneous / Q000473:pathology* / Q000503:physiopathology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness / Q000473:pathology*; D009367:Neoplasm Staging; D018714:Radiotherapy, Adjuvant; D018570:Risk Assessment; D012878:Skin Neoplasms / Q000473:pathology* / Q000503:physiopathology / Q000628:therapy
D019002:CD56 Antigen